# Organ Transplantation Market and Forecast 2025-2033

Limited-Time Offer \[Flat 15% Discount\] [Dismiss](#)

[Skip to content](#content "Skip to content")

[Updated Data Matrix Available](https://www.ihealthcareanalyst.com/research-services/)

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

[Home](https://www.ihealthcareanalyst.com/) » [Reports](https://www.ihealthcareanalyst.com/shop/) » [Biotechnology](https://www.ihealthcareanalyst.com/reports/biotechnology/amp/)

![Awaiting product image](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)

![Awaiting product image](https://www.ihealthcareanalyst.com/wp-content/uploads/2019/08/report-icon4-e1565791186498.png)

# Organ Transplantation Market by Product (Tissue / Organ Products, Immunosuppressive Drugs, Preservation Solutions), Application / Organ Type (Tissue Transplant, Organ Transplant), End User (Hospitals, Transplant Centers, Others) and Forecast 2025-2033

$3,000.00

## Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Organ transplantation involves replacing the damaged or diseased organ with a healthy organ by transferring of functional, intact organ from one individual to another. The organs can be donated by the living donors or even harvested from the organ donors that are brain-dead.

Advances in the technology and development within the medical sector has made it possible to transplant organs such as heart, kidney, liver, lungs, and various other [organs](https://www.ihealthcareanalyst.com/report/artificial-vital-organs-medical-bionics-market/). The major technical breakthroughs include developing techniques for vascular anastomoses, managing the immune response (chemical [immunosuppressants](https://www.ihealthcareanalyst.com/report/organ-transplant-immunosuppressant-drugs-market/)), and devising preservation [solutions](https://www.ihealthcareanalyst.com/report/organ-preservation-solutions-market/).

Organ transplants include single-organ transplants such as heart, intestine, kidney, liver, lung, pancreas, and several multiple-organ transplants. Tissue transplants include bone marrow and corneal transplants. International variation in transplantation activities is recognized to be largely unrelated to the actual distribution of medical need and correlated instead with the resources available for healthcare provision.

The global organ transplantation market research report provides market size (Revenue $million 2023 to 2033), market share analysis, growth trends and forecast (CAGR%, 2025 to 2033).

The global organ transplantation market segmentation is based on product (tissue / organ products, immunosuppressive drugs, preservation solutions), application/ organ type (tissue transplant, organ transplant), end user (hospitals, transplant centers, others) and geography.

The tissue transplants include heart valve, vascular grafts, bone grafts, cornea, skin grafts, bone marrow, other tissues. The organ transplants include kidney transplant, liver transplant, heart transplant, lung transplant, pancreas transplant, other organs.

The global organ transplantation market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

In addition, the global organ transplantation market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries.  The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major players operating in the global organ transplantation market and profiled in this report include 21st Century Medicine, AbbVie, Inc., Arthrex, Inc., Astellas Pharma, Inc., Bio-Med Pvt. Ltd., BioLifeSolutions, Inc., Chiesi Farmaceutici S.p.A., GlaxoSmithKline plc, Hansa Biopharma AB (Hansa Medical AB), Intas Pharmaceuticals Ltd. (Accord Healthcare GmbH), Medtronic plc, Novartis AG, OrganOX Limited, Pfizer, Inc., Preservation Solutions, Inc., Roche Holding AG (F. Hoffmann-La Roche AG), Sanofi S.A., Stryker Corporation, Terumo Medical Corporation, Teva Pharmaceutical Industries Ltd., TransMedics, Inc., Transonic Systems, Inc., Transplant Biomedical SL, Veloxis Pharmaceuticals A/S, and Zimmer Biomet.

**DATA INCLUDED:** Organ Transplantation Market Size, Organ Transplantation Market Share, Organ Transplantation Market Growth Rates, Organ Transplantation Market Trends, and Organ Transplantation Market Forecast to 2033

**Market Data:**

*   Estimation Base Year: 2024
*   Historical Data Range: 2023-2024
*   Forecast Period: 2025-2033
*   Market Representation: Revenue in $million and CAGR % from 2025 to 2033
*   Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
*   Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
*   Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
*   Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.

**Qualitative Analysis:**

*   Industry Overview
*   Industry Trends
*   Market Driver, Restraints, and Opportunities
*   Market Size
*   Growth Trends
*   Porter’s Five Forces Analysis
*   Market Attractiveness Matrix
*   Competitive Landscape
    *   Company Overview
    *   Financial Performance
    *   Product Portfolio
    *   Strategic Insights
    *   Recent Developments

**Quantitative Analysis:**

*   Market Size Projections: Comprehensive estimates and forecasts for all segments
*   Regional Market Analysis: Estimates and forecasts for key countries
*   Corporate Financial Performance: Analysis of company financials
*   Competitive Landscape: Market share analysis of leading companies

Choose License Type

Choose an optionSingle-user LicenseMulti-user LicenseCorporate License[Clear](#)

Organ Transplantation Market by Product (Tissue / Organ Products, Immunosuppressive Drugs, Preservation Solutions), Application / Organ Type (Tissue Transplant, Organ Transplant), End User (Hospitals, Transplant Centers, Others) and Forecast 2025-2033 quantity 

Buy Report   

For inquiries regarding discounts on single or bundled report purchases, please reach out to us.

*   [Table of Contents BT](#tab-table-of-contents-bt)
*   [Market Segments and Companies](#tab-market-segments-and-companies)
*   [Request ToC / Sample](#tab-request-toc-sample-discount)

1.  **Introduction**
2.  **Executive Summary**
    *   Market Size Estimation ($million, 2023-2033)
    *   Forecast Estimation ($million and CAGR%, 2025-2033)
3.  [**Research Methodology**](https://www.ihealthcareanalyst.com/research-methodology/)
4.  **Market Landscape**
    *   Market Dynamics
        *   Drivers
        *   Barriers
        *   Opportunities
    *   Market Share Analysis
        *   Companies
        *   Products
    *   Market Trends Analysis
        *   Key success factors
        *   Market Growth Rate
    *   Market Attractiveness Analysis
    *   Market Profitability Analysis
        *   Buyer power
        *   Supplier power
        *   Barriers to entry
        *   Threat of substitute products
        *   Rivalry among firms in the industry
    *   Distribution Channels
5.  **Market Segmentation** \[_refer_ _Market Segments and Companies Tab_\]
    *   Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    *   Source Type
    *   Reagents and Consumables Type
    *   Diagnostic Test
    *   Indication Type
    *   Technology
    *   Diagnostics, Therapeutic or Surgical Application
    *   End User Groups
6.  **Geography (Region, Country)**
    *   North America (U.S., Canada)
    *   Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    *   Asia Pacific (Japan, China, India, Rest of APAC)
    *   Latin America (Brazil, Mexico, Rest of LA)
    *   Rest of the World (Middle East & Africa)
7.  **Company Profiles** \[_refer_ _Market Segments and Companies Tab_\]
    *   Company Overview
    *   Financial Snapshot
    *   Product Portfolio
    *   Business Strategies
    *   Recent Developments
8.  **Recommendations**
9.  **References**

**Key Questions Answered:**  
1\. What are the factors driving and limiting this market, key success factors and challenges?  
2\. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?  
3\. How do markets perform between countries and regions?  
4\. What market segments are contributing to maximum share and greatest growth?  
5\. What is the product or procedure volumes by country and regions?

**Actionable Insights Included:**  
1\. Product portfolio matrix (Share vs. Growth)  
2\. Market attractiveness (Region vs. Growth)  
3\. Spot matrix (Product vs. Region)  
4\. Geographic distribution matrix (Share vs. Growth)

**Organ Transplantation Market**

1\. **Product**  
1.1. Tissue / Organ Products  
1.2. Immunosuppressive Drugs  
1.3. Organ Preservation Solutions

2\. **Application/ Organ Type**  
2.1. Tissue Transplants (Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues)  
2.2. Organ Transplants (Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant)

3\. **End User**  
3.1. Hospitals  
3.2. Transplant Centers  
3.3. Others

4\. **Geography**  
4.1. North America (U.S., Canada)  
4.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)  
4.3. Asia Pacific (Japan, China, India, Rest of APAC)  
4.4. Latin America (Brazil, Mexico, Rest of LA)  
4.5. Rest of the World

5\. **Company Profiles**  
5.1. 21st Century Medicine  
5.2. AbbVie, Inc.  
5.3. Arthrex, Inc.  
5.4. Astellas Pharma, Inc.  
5.5. Bio=Med Pvt. Ltd.  
5.6. BioLifeSolutions, Inc.  
5.7. Chiesi Farmaceutici S.p.A.  
5.8. GlaxoSmithKline plc  
5.9. Hansa Biopharma AB (Hansa Medical AB)  
5.10. Intas Pharmaceuticals Ltd. (Accord Healthcare GmbH)  
5.11. Medtronic plc  
5.12. Novartis AG  
5.13. OrganOX Limited  
5.14. Pfizer, Inc.  
5.15. Preservation Solutions, Inc.  
5.16. Roche Holding AG (F. Hoffmann-La Roche AG)  
5.17. Sanofi S.A.  
5.18. Stryker Corporation  
5.19. Terumo Medical Corporation  
5.20. Teva Pharmaceutical Industries Ltd.  
5.21. TransMedics, Inc.  
5.22. Transonic Systems, Inc.  
5.23. Transplant Biomedicals SL  
5.24. Veloxis Pharmaceuticals A/S  
5.25. Zimmer Biomet

**Request Table of Contents / Sample Report**

Full Name\*

Company Email\*

Phone Number\* \[Please add country code\]

Subject\*

Message\*

Resource Links

*   [About Us](https://www.ihealthcareanalyst.com/about/)
*   [Clinical Trials](https://www.ihealthcareanalyst.com/clinical-trials-dashboard/)
*   [Drugs@FDA](https://www.ihealthcareanalyst.com/drugs-fda-dashboard/)
*   [Orange Book](https://www.ihealthcareanalyst.com/orange-book-dashboard/)
*   [Premarket Approval](https://www.ihealthcareanalyst.com/premarket-approval-pma/)
*   [Premarket Notification](https://www.ihealthcareanalyst.com/premarket-notification-510k/)
*   [Publications](https://www.ihealthcareanalyst.com/publications/)

Terms and Conditions

*   [FAQs](https://www.ihealthcareanalyst.com/faqs/)
*   [Careers](https://www.ihealthcareanalyst.com/careers/)
*   [Terms of Use](https://www.ihealthcareanalyst.com/terms/)
*   [How to Order](https://www.ihealthcareanalyst.com/order/)
*   [Return Policy](https://www.ihealthcareanalyst.com/return/)
*   [Privacy Policy](https://www.ihealthcareanalyst.com/privacy/)
*   [Disclaimer Policy](https://www.ihealthcareanalyst.com/disclaimer/)

Secure Online Payment

![iHealthcareAnalyst, Inc.](https://www.ihealthcareanalyst.com/wp-content/uploads/2018/07/creditcard-payment-logos-300x48.jpg)

Search

Search

Contact Address

**US Office:** 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States  
Phone: +1 (314) 315-4764  
**India Office:** 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India  
Phone: +91 (20) 25898524  
Email: [\[email protected\]](/cdn-cgi/l/email-protection#295a48454c5a6940414c48455d414a485b4c48474845505a5d074a4644)

[](# "Scroll back to top")

Search for: